Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p
- PMID: 34632534
- DOI: 10.1007/s00335-021-09923-y
Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p
Retraction in
-
Retraction Note: Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p.Mamm Genome. 2023 Sep;34(Suppl 1):2. doi: 10.1007/s00335-023-10001-8. Mamm Genome. 2023. PMID: 37306744 No abstract available.
Abstract
Researches indicate that circular RNAs are dysregulated in breast cancer (BC) and play a critical role in regulating the malignant phenotype of cancer cells. Herein, the goal of this work was to investigate the role and mechanism of circ_0069718 in BC development. Levels of genes and proteins were detected by quantitative real-time polymerase chain reaction and western blot. In vitro experiments were performed using cell counting kit-8 assay, colony formation assay, EdU (5-ethynyl-2'-deoxyuridine) assay, flow cytometry, western blot, and transwell assay, respectively. The dual-luciferase reporter and RNA immunoprecipitation assays were used to identify the target relationship between miR-590-5p and circ_0069718 or nuclear factor I/B (NFIB). In vivo experiments were conducted using Xenograft model in mice. Circ_0069718 was up-regulated in BC tissues and cells. Knockdown of circ_0069718 suppressed BC cell apoptosis, migration, and invasion in vitro effectively. Mechanistically, circ_0069718 directly targeted miR-590-5p to up-regulate its target NFIB. Rescue experiments showed that miR-590-5p inhibition reversed the inhibitory effects of circ_0069718 knockdown on BC cell-aggressive oncogenic phenotypes; moreover, miR-590-5p re-expression restrained BC cell proliferation and mobility, which were abolished by NFIB up-regulation. Besides that, circ_0069718 silencing hindered tumor growth via miR-590-5p/NFIB axis in vivo. Circ_0069718 promotes BC progression by up-regulating NFIB through sequestering miR-590-5p, suggesting a potential therapeutic strategy in BC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Sevoflurane inhibits the malignant phenotypes of glioma through regulating miR-146b-5p/NFIB axis.Metab Brain Dis. 2022 Jun;37(5):1373-1386. doi: 10.1007/s11011-022-00959-w. Epub 2022 Apr 7. Metab Brain Dis. 2022. PMID: 35386035
-
Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.Anticancer Drugs. 2023 Feb 1;34(2):214-226. doi: 10.1097/CAD.0000000000001406. Epub 2022 Nov 15. Anticancer Drugs. 2023. PMID: 36730637
-
Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis.Bioengineered. 2022 Feb;13(2):1963-1974. doi: 10.1080/21655979.2021.1995990. Bioengineered. 2022. PMID: 34787066 Free PMC article.
-
Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.Thorac Cancer. 2020 Jul;11(7):1891-1903. doi: 10.1111/1759-7714.13475. Epub 2020 May 23. Thorac Cancer. 2020. PMID: 32445273 Free PMC article.
-
Nuclear factor I/B: Duality in action in cancer pathophysiology.Cancer Lett. 2025 Jan 28;609:217349. doi: 10.1016/j.canlet.2024.217349. Epub 2024 Nov 22. Cancer Lett. 2025. PMID: 39581218 Review.
Cited by
-
hsa_circ_0010889 downregulation inhibits malignant glioma progression by modulating the miR-590-5p/SATB1 axis.Aging (Albany NY). 2023 Aug 3;15(15):7440-7450. doi: 10.18632/aging.204907. Epub 2023 Aug 3. Aging (Albany NY). 2023. PMID: 37540226 Free PMC article.
References
-
- Cai W, Xu Y, Yin J, Zuo W, Su Z (2018) miR-590-5p suppresses osteosarcoma cell proliferation and invasion via targeting KLF5. Mol Med Rep 18(2):2328–2334 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical